UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
기사
(전체 8건)
제목보기
제목보기
제목+내용
기사보기
‘Stem cell therapy’s problem? No hit item yet’
Stem cells, which can be...
Nam Doo-hyun
|
2017-07-19 18:16
기사보기
'Bio ventures are for developing new drugs, not making cosmetics'
Bio ventures promoting c...
Nam Doo-hyun
|
2017-06-19 14:47
기사보기
Expert laments three 'nos' in drug industry
Practically every pharma...
Nam Doo-hyun
|
2017-03-03 11:32
기사보기
Can Hongneung area be reborn as 'bio cluster'?
A biomedical industrial ...
Nam Doo-hyun
|
2017-02-27 17:08
기사보기
'Troublemaker Doctor' out of the Hospital and into the Hot Bio-Industry
Ever since the various a...
Nam Doo-hyun
|
2017-02-16 08:30
기사보기
It’s a War, Not a Battle
GemVax & KAEL is one of Korea’s top bio busi...
Nam Doo-hyun
|
2017-02-15 08:00
기사보기
Korea’s Gene Analysis Technology Goes Global with Spearhead Macrogen
With the rise of gene me...
Nam Doo-hyun
|
2017-02-07 12:27
기사보기
"Why Make Luxury Sports Cars We Can't Sell Overseas? We Need Strong Bioregulations"
Nam Doo-hyun
|
2016-12-29 08:04
-
1
-
Back to Top